| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.01 |